Low brain iron effects and reversibility on striatal dopamine dynamics

Experimental Neurology

Volumn 261, Issue , 2014, Pages 462-468

  Unger, Erica L ^a   Bianco, Laura E ^a   Jones, Byron C ^a   Allen, Richard P ^b   Earley, Christopher J ^b  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dopamine; Iron deficiency; Microdialysis; Restless legs syndrome; Striatum; Ventral midbrain

Indexed keywords

DOPAMINE; DOPAMINE 2 RECEPTOR STIMULATING AGENT; IRON; QUINPIROLE; FERROUS ION; FERROUS SULFATE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; FEEDBACK SYSTEM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IRON DEFICIENCY; LIPID PEROXIDATION; MALE; MESENCEPHALON; MICRODIALYSIS; MOLECULAR DYNAMICS; NONHUMAN; PHOTOMETRY; PRIORITY JOURNAL; PROTEIN TRANSPORT; RAT; TEMPERATURE; TISSUE HOMOGENATE; TISSUE LEVEL; BRAIN LEVEL; DIETARY INTAKE; DOPAMINE UPTAKE; IRON BLOOD LEVEL; RESTLESS LEGS SYNDROME; WEANING; ADVERSE EFFECTS; ANIMAL; BRAIN; CORPUS STRIATUM; DEFICIENCY; DIET; DISEASE MODEL; DRUG EFFECTS; HYDRODYNAMICS; IRON METABOLISM DISORDERS; METABOLISM; NEWBORN; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ANIMALS, NEWBORN; BRAIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORPUS STRIATUM; DIET; DISEASE MODELS, ANIMAL; DOPAMINE; FERROUS COMPOUNDS; HYDRODYNAMICS; IRON; IRON METABOLISM DISORDERS; LIPID PEROXIDATION; MALE; MICRODIALYSIS; RATS; RATS, SPRAGUE-DAWLEY; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 84905825718     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2014.06.023     Document Type: Article

References (48)

1. Allen R.P., Earley C.J. Augmentation of the restless legs syndrome with carbidopa/levodopa. Sleep 1996, 19:205-213.
2. Allen R.P., Barker P.B., Wehrl F., Song H.K., Earley C.J. MRI measurement of brain iron in patients with restless legs syndrome. Neurology 2001, 56:263-265.
3. Allen R.P., Auerbach S., Bahrain H., Auerbach M., Earley C.J. The prevalence and impact of restless legs syndrome on patients with iron deficiency anemia. Am. J. Hematol. 2013, 88:261-264.
4. Beard J.L., Connor J.R. Iron status and neural functioning. Annu. Rev. Nutr. 2003, 020102:075739.
5. Beard J.L., Chen Q., Connor J., Jones B.C. Altered monamine metabolism in caudate-putamen of iron-deficient rats. Pharmacol. Biochem. Behav. 1994, 48:621-624.
6. Ben-Shachar D., Youdim M. Intranigral iron injection induces behavioral and biochemical "parkinsonism" in rats. J. Neurochem. 1991, 57:2133-2135.
7. Bianco L.E., Wiesinger J., Earley C.J., Jones B.C., Beard J.L. Iron deficiency alters dopamine uptake and response to L-DOPA injection in Sprague-Dawley rats. J. Neurochem. 2008, 106:205-215.
8. Bianco L.E., Unger E.L., Earley C.J., Beard J.L. Iron deficiency alters the day-night variation in monoamine levels in mice. Chronobiol. Int. 2009, 26:447-463.
9. Bolan E.A., Kivell B., Jaligam V., Oz M., Jayanthi L.D., Han Y., Sen N., Urizar E., Gomes I., Devi L.A., Ramamoorthy S., Javitch J.A., Zapata A., Shippenberg T.S. D2 receptors regulate dopamine transporter function via an extracellular signal-regulated kinases 1 and 2-dependent and phosphoinositide 3 kinase-independent mechanism. Mol. Pharmacol. 2007, 71:1222-1232.
10. Bungay P.M., Newton-Vinson P., Isele W., Garris P.A., Justice J.B. Microdialysis of dopamine interpreted with quantitative model incorporating probe implantation trauma. J. Neurochem. 2003, 86:932-946.
11. Chefer V.I., Zapata A., Shippenberg T.S., Bungay P.M. Quantitative no-net-flux microdialysis permits detection of increases and decreases in dopamine uptake in mouse nucleus accumbens. J. Neurosci. Methods 2006, 155:187-193.
12. Connor J.R., Menzies S.L., St.Martin, S.M., and Mufson, E.J., A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains. J. Neurosci. Res. 1992, 31:75-83.
13. Connor J.R., Boyer P.J., Menzies S.L., Dellinger B., Allen R.P., Earley C.J. Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology 2003, 61:304-309.
14. Connor J.R., Wang X.S., Allen R.P., Beard J.L., Wiesinger J.A., Felt B.T., Earley C.J. Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome. Brain 2009, 132:2403-2412.
15. Conrad M.E., Umbreit J.N. Iron absorption and transport-an update. Am. J. Hematol. 2000, 64:287-298.
16. Cooper J.R., Bloom F.E., Roth R.H. The Biochemical Basis of Neuropharmacology 2008, Oxford University Press, New York.
17. Earley C.J. Clinical practice. Restless legs syndrome. N. Engl. J. Med. 2003, 348:2103-2109.
18. Earley C.J., Kuwabara H., Wong D.F., Gamaldo C., Salas R., Brasic J., Ravert H.T., Dannals R.F., Allen R.P. The dopamine transporter is decreased in the striatum of subjects with restless legs syndrome. Sleep 2011, 34:341-347.
19. Earley C.J., Kuwabara H., Wong D.F., Gamaldo C., Salas R.E., Brasic J.R., Ravert H.T., Dannals R.F., Allen R.P. Increased synaptic dopamine in the putamen in restless legs syndrome. Sleep 2013, 36:51-57.
20. Erikson K.M., Jones B.C., Beard J.L. Iron deficiency alters dopamine transporter functioning in rat striatum. J. Nutr. 2000, 130:2831-2837.
21. Erikson K.M., Jones B.C., Hess E.J., Zhang Q., Beard J.L. Iron deficiency decreases dopamine D1 and D2 receptors in rat brain. Pharmacol. Biochem. Behav. 2001, 69:409-418.
22. Garcia-Borreguero D. Augmentation: understanding a key feature of RLS. Sleep Med. 2004, 5:5-6.
23. Godau J., Schweitzer K.J., Liepelt I., Gerloff C., Berg D. Substantia nigra hypoechogenicity: definition and findings in restless legs syndrome. Mov. Disord. 2007, 22:187-192.
24. Haeger P., Alvarez A., Leal N., Adasme T., Nunez M.T., Hidalgo C. Increased hippocampal expression of the divalent metal transporter 1 (DMT1) mRNA variants 1B and +IRE and DMT1 protein After NMDA-receptor stimulation or spatial memory training. Neurotox. Res. 2010, 17:238-247.
25. Jellen L.C., Unger E.L., Lu L., Williams R., Rousseau S., Wang X., Earley C.J., Allen R.P., Miles M., Jones B.C. Systems genetic analysis of the effects of iron deficiency in mouse brain. Neurogenetics 2012, 13:147-157.
26. Lee B.-Y., Farace E., Vesek J., Connor J., Yang Q. In vivo measurement of iron deficiency in restless legs syndrome (RLS) with voxel-based R2 relaxometry. Proc. Int. Soc. Magn. Reson. Med. 2007, 15:2170.
27. Mao A., Freeman K.A., Tallarida R.J. Transient loss of dopamine autoreceptor control in the presence of highly potent dopamine agonists. Life Sci. 1996, 59:L317-L324.
28. Mefford I.N. Application of high performance liquid chromatography with electrochemical detection to neurochemical analysis: measurement of catecholamines, serotonin and metabolites in rat brain. J. Neurosci. Methods 1981, 3:207-224.
29. Moos T. Brain iron homeostasis. Dan. Med. Bull. 2002, 49:279-301.
30. 2+ influx through N-methyl-D-aspartate receptor channels in immature cultured rat cortical neurons. J. Neurochem. 2002, 83:1-11.
31. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979, 95:351-358.
32. Prikhojan A., Brannan T., Yahr M.D. Intrastriatal iron perfusion releases dopamine: an in-vivo microdialysis study. J. Neural Transm. 2002, 109:645-649.
33. Reeves P.G., Nielsen F.H., Fahey G.C. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 1993, 123:1939-1951.
34. Refshauge C., Kissinger P.T., Dreiling R., Blank L., Freeman R., Adams R.N. New high performance liquid chromatographic analysis of brain catecholamines. Life Sci. 1974, 14:311-322.
35. Rice M.E. Ascorbate regulation and its neuroprotective role in the brain. Trends Neurosci. 2000, 23:209-216.
36. Rizzo G., Manners D., Testa C., Tonon C., Vetrugno R., Marconi S., Plazzi G., Pizza F., Provini F., Malucelli E., Gramegna L.L., Lodi R. Low Brain Iron Content in Idiopathic Restless Legs Syndrome Patients Detected by Phase Imaging 2013, Mov Disord.
37. Robinson M.B. Regulated trafficking of neurotransmitter transporters: common notes but different melodies. J. Neurochem. 2002, 80:1-11.
38. 2+ channels. Brain Res. 2005, 1047:18-29.
39. Santiago M., Matarredona E.R., Granero L., Cano J., Machado A. Neurotoxic relationship between dopamine and iron in the striatal dopaminergic nerve terminals. Brain Res. 2000, 858:26-32.
40. Schmidauer C., Sojer M., Seppi K., Stockner H., Hogl B., Biedermann B., Brandauer E., Peralta C.M., Wenning G.K., Poewe W. Transcranial ultrasound shows nigral hypoechogenicity in restless legs syndrome. Ann. Neurol. 2005, 58:630-634.
41. See R.E., Sorg B.A., Chapman M.A., Kalivas P.W. In vivo assessment of release and metabolism of dopamine in the ventrolateral striatum of awake rats following administration of dopamine D1 and D2 receptor agonists and antagonists. Neuropharmacology 1991, 30:1269-1274.
42. Smith A.D., Justice J.B. The effect of inhibition of synthesis, release, metabolism and uptake on the microdialysis extraction fraction of dopamine. J. Neurosci. Methods 1994, 54:75-82.
43. Trenkwalder C., Walters A., Hening W., etal Circadian rhythm of patients with the idiopathic restless legs syndrome. Sleep Res. 1995, 24:360.
44. Unger E.L., Beard J.L., Jones B.C. Iron regulation in C57BLI6 and DBA/2 mice subjected to iron overload. Nutr. Neurosci. 2007, 10:89-95.
45. Unger E.L., Wiesinger J.A., Hao L., Beard J.L. Dopamine D2 receptor expression is altered by changes in cellular iron levels in PC12 cells and rat brain tissue. J. Nutr. 2008, 138:2487-2494.
46. Unger E.L., Earley C.J., Thomsen L.L., Jones B.C., Allen R.P. Effects of IV iron isomaltoside-1000 treatment on regional brain iron status in an iron-deficient animal. Neuroscience 2013, 246:179-185.
47. Wiesinger J.A., Buwen J.P., Cifelli C.J., Unger E.L., Jones B.C., Beard J.L. Down-regulation of dopamine transporter by iron chelation in vitro is mediated by altered trafficking, not synthesis. J. Neurochem. 2007, 100:167-179.
48. Yin L., Unger E.L., Jellen L.C., Earley C.J., Allen R.P., Tomaszewicz A., Fleet J.C., Jones B.C. Systems genetic analysis of multivariate response to iron deficiency in mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2012, 302:R1282-R1296.